Cold-inducible RNA-binding protein mediates neuroinflammation in cerebral ischemia

Background: Neuroinflammation is a key cascade after cerebral ischemia. Excessive production of proinflammatory mediators in ischemia exacerbates brain injury. Cold-inducible RNA-binding protein (CIRP) is a newly discovered proinflammatory mediator that can be released into the circulation during hemorrhage or septic shock. Here, we examine the involvement of CIRP in brain injury during ischemic stroke. Methods: Stroke was induced by middle cerebral artery occlusion (MCAO). In vitro hypoxia was conducted in a hypoxia chamber containing 1% oxygen. CIRP and tumor necrosis factor-alpha (TNF-alpha) levels were assessed by RT-PCR and Western blot analysis. Results: CIRP is elevated along with an upregulation of TNF-alpha expression in mouse brain after MCAO. In CIRP-deficient mice, the brain infarct volume, induction of TNF-alpha, and activation of microglia are markedly reduced after MCAO. Using microglial BV2 cells, we demonstrate that hypoxia induces the expression, translocation, and release of CIRP, which is associated with an increase of TNF-alpha levels. Addition of recombinant murine (rm) CIRP directly induces TNF-alpha release from BV2 cells and such induction is inhibited by neutralizing antisera to CIRP. Moreover, rmCIRP activates the NF-kappa B signaling pathway in BV2 cells. The conditioned medium from BV2 cells exposed to hypoxia triggers the apoptotic cascade by increasing caspase activity and decreasing Bcl-2 expression in neural SH-SY5Y cells, which is inhibited by antisera to CIRP. Conclusion: Extracellular CIRP is a detrimental factor in stimulating inflammation to cause neuronal damage in cerebral ischemia. General significance: Development of an anti-CIRP therapy may benefit patients with brain ischemia. (C) 2014 Elsevier B.V. All rights reserved.